Scientech Research’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
Other funds holding COGT
Scientech Research's COGT Position: Q2 2026 in Review
Scientech Research increased its Cogent Biosciences (COGT) stake by 123% in Q2 2026, buying an estimated $254K and bringing the position to 13,183 shares worth $510K. The position accounts for 0.41% of the portfolio, ranked #79.
Scientech Research first reported a position in COGT in Q4 2023 and has held it in 3 quarters since. 325 funds tracked by Wall St. Rank hold COGT as of Q2 2026.
- Scientech Research held 13,183 shares of Cogent Biosciences worth $510K as of Q2 2026.
- Scientech Research bought 7,264 Cogent Biosciences shares in Q2 2026, an estimated $254K.
- Cogent Biosciences made up 0.41% of Scientech Research's portfolio in Q2 2026, its #79 holding.
- Scientech Research first reported a position in Cogent Biosciences in Q4 2023 and has held it in 3 quarters since.
- 325 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.